205 related articles for article (PubMed ID: 27399121)
41. Predictors of perioperative blood loss in total joint arthroplasty.
Park JH; Rasouli MR; Mortazavi SM; Tokarski AT; Maltenfort MG; Parvizi J
J Bone Joint Surg Am; 2013 Oct; 95(19):1777-83. PubMed ID: 24088970
[TBL] [Abstract][Full Text] [Related]
42. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
43. Allogeneic Blood Transfusion Is a Significant Risk Factor for Surgical-Site Infection Following Total Hip and Knee Arthroplasty: A Meta-Analysis.
Kim JL; Park JH; Han SB; Cho IY; Jang KM
J Arthroplasty; 2017 Jan; 32(1):320-325. PubMed ID: 27682006
[TBL] [Abstract][Full Text] [Related]
44. Perioperative blood salvage as an alternative to predonating blood for primary total knee and hip arthroplasty.
Friederichs MG; Mariani EM; Bourne MH
J Arthroplasty; 2002 Apr; 17(3):298-303. PubMed ID: 11938505
[TBL] [Abstract][Full Text] [Related]
45. Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.
Huang ZY; Huang Q; Zeng HJ; Ma J; Shen B; Zhou ZK; Pei FX
BMC Musculoskelet Disord; 2019 Sep; 20(1):402. PubMed ID: 31481049
[TBL] [Abstract][Full Text] [Related]
46. The Michigan Experience with Safety and Effectiveness of Tranexamic Acid Use in Hip and Knee Arthroplasty.
Hallstrom B; Singal B; Cowen ME; Roberts KC; Hughes RE
J Bone Joint Surg Am; 2016 Oct; 98(19):1646-1655. PubMed ID: 27707851
[TBL] [Abstract][Full Text] [Related]
47. Cost Analysis of Tranexamic Acid in Anemic Total Joint Arthroplasty Patients.
Phan DL; Ani F; Schwarzkopf R
J Arthroplasty; 2016 Mar; 31(3):579-82. PubMed ID: 26601635
[TBL] [Abstract][Full Text] [Related]
48. Does exercise reduce pain and improve physical function before hip or knee replacement surgery? A systematic review and meta-analysis of randomized controlled trials.
Gill SD; McBurney H
Arch Phys Med Rehabil; 2013 Jan; 94(1):164-76. PubMed ID: 22960276
[TBL] [Abstract][Full Text] [Related]
49. Effect of Erythropoietin on Transfusion Requirements for Craniosynostosis Surgery in Children.
Aljaaly HA; Aldekhayel SA; Diaz-Abele J; Karunanayka M; Gilardino MS
J Craniofac Surg; 2017 Jul; 28(5):1315-1319. PubMed ID: 28582302
[TBL] [Abstract][Full Text] [Related]
50. Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.
Quirt I; Micucci S; Moran LA; Pater J; Browman G
Cancer Prev Control; 1997 Aug; 1(3):241-8. PubMed ID: 9765749
[TBL] [Abstract][Full Text] [Related]
51. Anaesthetic care of patients undergoing primary hip and knee arthroplasty: consensus recommendations from the International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) based on a systematic review and meta-analysis.
Memtsoudis SG; Cozowicz C; Bekeris J; Bekere D; Liu J; Soffin EM; Mariano ER; Johnson RL; Hargett MJ; Lee BH; Wendel P; Brouillette M; Go G; Kim SJ; Baaklini L; Wetmore D; Hong G; Goto R; Jivanelli B; Argyra E; Barrington MJ; Borgeat A; De Andres J; Elkassabany NM; Gautier PE; Gerner P; Gonzalez Della Valle A; Goytizolo E; Kessler P; Kopp SL; Lavand'Homme P; MacLean CH; Mantilla CB; MacIsaac D; McLawhorn A; Neal JM; Parks M; Parvizi J; Pichler L; Poeran J; Poultsides LA; Sites BD; Stundner O; Sun EC; Viscusi ER; Votta-Velis EG; Wu CL; Ya Deau JT; Sharrock NE
Br J Anaesth; 2019 Sep; 123(3):269-287. PubMed ID: 31351590
[TBL] [Abstract][Full Text] [Related]
52. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Aher SM; Ohlsson A
Cochrane Database Syst Rev; 2014 Apr; (4):CD004868. PubMed ID: 24760628
[TBL] [Abstract][Full Text] [Related]
53. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty.
Jans Ø; Jørgensen C; Kehlet H; Johansson PI;
Transfusion; 2014 Mar; 54(3):717-26. PubMed ID: 23829298
[TBL] [Abstract][Full Text] [Related]
54. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2012 Sep; (9):CD004863. PubMed ID: 22972076
[TBL] [Abstract][Full Text] [Related]
55. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle.
Kotzé A; Carter LA; Scally AJ
Br J Anaesth; 2012 Jun; 108(6):943-52. PubMed ID: 22593128
[TBL] [Abstract][Full Text] [Related]
56. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery.
Cuenca J; García-Erce JA; Martínez F; Pérez-Serrano L; Herrera A; Muñoz M
Transfusion; 2006 Jul; 46(7):1112-9. PubMed ID: 16836557
[TBL] [Abstract][Full Text] [Related]
57. Preoperative optimisation of anaemia for primary total hip arthroplasty: a systematic review.
Alexander DP; Frew N
Hip Int; 2017 Nov; 27(6):515-522. PubMed ID: 28605004
[TBL] [Abstract][Full Text] [Related]
58. Combined versus single application of tranexamic acid in total knee and hip arthroplasty: A meta-analysis of randomized controlled trials.
Peng Zhang MM; Jifeng Li MM; Xiao Wang MM
Int J Surg; 2017 Jul; 43():171-180. PubMed ID: 28602763
[TBL] [Abstract][Full Text] [Related]
59. Preoperative Blood Management Strategy for Elective Hip and Knee Arthroplasty.
Kurian DJ; Guinn NR; Hunting J; Gamble JF; Hopkins TJ; Grimsley A; Guercio JR; Bolognesi MP; Schroeder R; Aronson S
J Healthc Qual; 2019; 41(6):376-383. PubMed ID: 31211739
[TBL] [Abstract][Full Text] [Related]
60. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction.
Lofthouse RA; Boitano MA; Davis JR; Jinnah RH
J South Orthop Assoc; 2000; 9(3):175-81. PubMed ID: 12135299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
